Tobias Walbert, MD, PhD, MPH
Co Director Hermelin Brain Tumor Center at Henry Ford Health System.
Outcomes for patients with malignant brain tumors are divided into either clinical outcomes (COs) or patient-reported outcomes (PROs). Clinical outcomes are measured by the...
